{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:58:59Z","timestamp":1778565539650,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics &amp; Development"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1016\/s0959-437x(02)00302-7","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T07:58:07Z","timestamp":1034323087000},"page":"299-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Genetics of Parkinson's disease and biochemical studies of implicated gene products"],"prefix":"10.1016","volume":"12","author":[{"suffix":"Jr","given":"Peter T","family":"Lansbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Brice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0959-437X(02)00302-7_BIB1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80629-7","article-title":"New animal models for Parkinson's disease","volume":"101","author":"Dawson","year":"2000","journal-title":"Cell"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB2","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial","volume":"284","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/mds.1221","article-title":"Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Mov patients with the alpha-synuclein (G209A) mutation","volume":"16","author":"Bostantjopoulou","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/jnnp.70.5.662","article-title":"Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease","volume":"70","author":"Papapetropoulos","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.67","article-title":"Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation","volume":"49","author":"Spira","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ana.1027","article-title":"Parkinson's disease is not associated with the combined alpha-synuclein\/apolipoprotein E susceptibility genotype","volume":"49","author":"Khan","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(01)01557-9","article-title":"Genetic studies in Parkinson's disease with an alpha-synuclein\/NACP gene polymorphism in Japan","volume":"300","author":"Izumi","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB10","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/hmg\/10.17.1847","article-title":"alpha-Synuclein gene haplotypes are associated with Parkinson's disease","volume":"10","author":"Farrer","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB12","doi-asserted-by":"crossref","first-page":"43495","DOI":"10.1074\/jbc.C100551200","article-title":"Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations","volume":"276","author":"Uversky","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB13","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.1074\/jbc.M010907200","article-title":"Evidence for a partially folded intermediate in alpha-synuclein fibril formation","volume":"276","author":"Uversky","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB14","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB15","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/bi0102398","article-title":"Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease","volume":"40","author":"Volles","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB16","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M008919200","article-title":"A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly","volume":"276","author":"Giasson","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB17","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-5793(01)02597-2","article-title":"Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease","volume":"500","author":"Uversky","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB19","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1073\/pnas.171300598","article-title":"alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins","volume":"98","author":"Sharon","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB20","first-page":"916","article-title":"Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis","volume":"15","author":"Lee","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB21","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1074\/jbc.M108414200","article-title":"Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein","volume":"277","author":"Cole","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB22","doi-asserted-by":"crossref","first-page":"9927","DOI":"10.1021\/bi002952n","article-title":"Membrane binding and self-association of alpha-synucleins","volume":"40","author":"Narayanan","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB23","doi-asserted-by":"crossref","first-page":"41958","DOI":"10.1074\/jbc.M105022200","article-title":"Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins","volume":"276","author":"Perrin","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease","volume":"293","author":"Shimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB25","doi-asserted-by":"crossref","first-page":"34402","DOI":"10.1074\/jbc.M103766200","article-title":"Tetrahydrobiopterin scavenges superoxide in dopaminergic neurons","volume":"276","author":"Nakamura","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB26","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1074\/jbc.M010316200","article-title":"alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases","volume":"276","author":"Ellis","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1471-4159.2001.00174.x","article-title":"Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease","volume":"76","author":"Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB28","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","article-title":"Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease","volume":"914","author":"Rockenstein","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0896-6273(01)00462-7","article-title":"beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor","volume":"32","author":"Hashimoto","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0169-328X(01)00257-1","article-title":"Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells","volume":"95","author":"Payton","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB32","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1471-4159.2001.00301.x","article-title":"Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations","volume":"77","author":"Kawamata","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB33","first-page":"916","article-title":"Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis","volume":"15","author":"Lee","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1531-8249(20010201)49:2<276::AID-ANA54>3.0.CO;2-2","article-title":"No evidence of association between a dopamine transporter gene polymorphism (1215A\/G) and Parkinson's disease","volume":"49","author":"Kimura","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/nbdi.2000.0326","article-title":"Genetic analysis of synphilin-1 in familial Parkinson's disease","volume":"8","author":"Farrer","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB36","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1046\/j.1471-4159.2001.00655.x","article-title":"Cytosolic O-glycosylation is abundant in nerve terminals","volume":"79","author":"Cole","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB37","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","article-title":"Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death","volume":"21","author":"Stefanis","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1101\/gr.165801","article-title":"Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element","volume":"11","author":"Touchman","year":"2001","journal-title":"Genome Res"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB39","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1074\/jbc.M105326200","article-title":"Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors","volume":"277","author":"Lee","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB40","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.2001.00474.x","article-title":"Proteasomal inhibition leads to formation of ubiquitin\/alpha-synuclein-immunoreactive inclusions in PC12 cells","volume":"78","author":"Rideout","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/10.9.919","article-title":"Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis","volume":"10","author":"Tanaka","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","article-title":"Proteasomal function is impaired in substantia nigra in Parkinson's disease","volume":"297","author":"McNaught","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB43","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group","volume":"342","author":"Lucking","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO;2-L","article-title":"Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype","volume":"48","author":"Klein","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.57.2.359","article-title":"The parkin gene is not involved in late-onset Parkinson's disease","volume":"57","author":"Oliveri","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB46","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/hmg\/10.16.1649","article-title":"The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism","volume":"10","author":"Hedrich","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1212\/WNL.56.4.463","article-title":"New mutation (R42P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism","volume":"56","author":"Terreni","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB48","doi-asserted-by":"crossref","unstructured":"West A, P\u00e9riquet M, Lincoln S, L\u00fccking CB, Nicholl D, Bonifati V, Rawal N, Gasser T, Lohmann E, Deleuze JF et al.: The complex relationship between parkin mutations and Parkinson's disease, Am J Hum Genet 2002, in press.","DOI":"10.1002\/ajmg.10525"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB49","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1086\/318791","article-title":"Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects","volume":"68","author":"Periquet","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB50","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.56.11.1573","article-title":"Parkin gene causing benign autosomal recessive juvenile parkinsonism","volume":"56","author":"Nisipeanu","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/jnnp.71.2.231","article-title":"Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism","volume":"71","author":"Kuroda","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB52","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1212\/WNL.56.4.555","article-title":"Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations","volume":"56","author":"van de Warrenburg","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB53","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1212\/WNL.56.12.1759","article-title":"The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations","volume":"56","author":"Portman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.74","article-title":"Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene","volume":"49","author":"Hilker","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB55","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ana.1132","article-title":"Lewy bodies and parkinsonism in families with parkin mutations","volume":"50","author":"Farrer","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1531-8249(200008)48:2<245::AID-ANA15>3.0.CO;2-2","article-title":"Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism","volume":"48","author":"Maruyama","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB57","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s100720170042","article-title":"The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease","volume":"22","author":"Bonifati","year":"2001","journal-title":"Neurol Sci"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB58","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/WNL.57.5.924","article-title":"Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations","volume":"57","author":"L\u00fccking","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.1143","article-title":"Parkin and Parkinson's: more than homonymy?","volume":"50","author":"Corti","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB60","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0092-8674(01)00407-X","article-title":"An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin","volume":"105","author":"Imai","year":"2001","journal-title":"Cell"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB61","doi-asserted-by":"crossref","first-page":"35661","DOI":"10.1074\/jbc.C000447200","article-title":"Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity","volume":"275","author":"Imai","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB62","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","article-title":"Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB63","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1074\/jbc.M109806200","article-title":"Parkin and CASK\/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain","volume":"277","author":"Fallon","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/301713","article-title":"Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum","volume":"62","author":"Briggs","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB65","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1212\/WNL.53.8.1858","article-title":"Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease","volume":"53","author":"Maraganore","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-510X(01)00555-X","article-title":"A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population","volume":"189","author":"Satoh","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.10079","article-title":"Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms","volume":"51","author":"Momose","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB68","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/319522","article-title":"Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36","volume":"68","author":"Valente","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB69","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/mds.10034","article-title":"Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families","volume":"16","author":"Bentivoglio","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/ana.10053","article-title":"PARK6-linked parkinsonism occurs in several European families","volume":"51","author":"Valente","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB71","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/322996","article-title":"Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36","volume":"69","author":"van Duijn","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB72","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.10106","article-title":"Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset","volume":"51","author":"Bonifati","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB73","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.10113","article-title":"A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1","volume":"51","author":"Funayama","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB74","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/WNL.57.6.1124","article-title":"Genome-wide scan for Parkinson's disease: the GenePD Study","volume":"57","author":"DeStefano","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB75","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1001\/jama.286.18.2239","article-title":"Complete genomic screen in Parkinson disease: evidence for multiple genes","volume":"286","author":"Scott","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB76","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1531-8249(20010201)49:2<263::AID-ANA50>3.0.CO;2-K","article-title":"Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene","volume":"49","author":"Pastor","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mds.1087","article-title":"The tau A0 allele in Parkinson's disease","volume":"16","author":"Golbe","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB78","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.1228","article-title":"Case-Control study of the extended tau gene haplotype in Parkinson's disease","volume":"50","author":"Maraganore","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB79","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1001\/jama.286.18.2324","article-title":"Tau and Parkinson disease","volume":"286","author":"Spillantini","year":"2001","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S0959-437X(02)00302-7_BIB80","first-page":"A200","article-title":"A susceptibility gene to late-onset idiopathic Parkinson's disease successfully mapped [Abstract 123]","volume":"69","author":"Hicks","year":"2001","journal-title":"Am J Hum Genet"}],"container-title":["Current Opinion in Genetics &amp; Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X02003027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X02003027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:25:24Z","timestamp":1760700324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X02003027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0959437X02003027"],"URL":"https:\/\/doi.org\/10.1016\/s0959-437x(02)00302-7","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Parkinson's disease and biochemical studies of implicated gene products","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0959-437X(02)00302-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}